Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor (Q40272648)

From Wikidata
Jump to navigation Jump to search
scientific article published on June 2006
edit
Language Label Description Also known as
English
Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor
scientific article published on June 2006

    Statements

    Development and validation of a drug activity biomarker that shows target inhibition in cancer patients receiving enzastaurin, a novel protein kinase C-beta inhibitor (English)
    0 references
    Lisa J Green
    Philip Marder
    Chad Ray
    Carolyn A Cook
    Susan Jaken
    Luna C Musib
    Michael Carducci
    Carolyn D Britten
    Michele Basche
    S Gail Eckhardt
    Donald Thornton
    1 June 2006
    11 Pt 1
    3408-3415

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit